Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer.

Bardia, A.,Mayer, I. A.,Diamond, J. R.,Moroose, R. L.,Isakoff, S. J.,Starodub, A. N.,Shah, N. C.,O'Shaughnessy, J.,Kalinsky, K.,Guarino, M.,Abramson, V.,Juric, D.,Tola...; J. Clin. Oncol.. 2017 Mar 16.

Phase Ib study of safety and pharmacokinetics of the PI3K inhibitor SAR245408 with the HER3 neutralizing human antibody SAR256212 in patients with solid tumors.

Abramson VG, Supko JG, Ballinger T, Cleary JM, Hilton JF, Tolaney S, Chau NG, Cho DC, Lager JJ, Pearlberg J, Shapiro GI, Arteaga CL; Clin. Cancer Res.. 2016-12-28.

Towards real-time topical detection and characterization of FDG dose infiltration prior to PET imaging.

Williams JM, Arlinghaus LR, Rani SD, Shone MD, Abramson VG, Pendyala P, Chakravarthy AB, Gorge WJ, Knowland JG, Lattanze RK, Perrin SR, Scarantino CW, Townsend DW, Abr...; Eur J Nucl Med Mol Imaging. 2016 Dec.